We are very pleased to announce that IJIC has received its first Impact Factor of 2.4 (from JCR).
We want to extend our gratitude to the authors, editors, and reviewers whose efforts helped us achieve this milestone!
International Journal of Industrial Chemistry (IJIC) [ISSN: 2228-5970, E-ISSN: 2228-5547] is an open-access, free of charge and peer-reviewed journal published every three months (four issues per year) by the OICC Press and distributed in the world is an international scientific journal.
Journal DOI: 10.57647/IJIC
We are now utilising the ScholarOne ManuscriptsTM platform (https://mc04.manuscriptcentral.com/ijic) to enhance the submission and peer-review processes. This change has streamlined our operations and will make your experience as an author/reviewer more efficient.
The new Editor-in-chief and Director-in-charge have started their work at the IJIC on 5th October 2023.
This study aims to probe the clinical efficacy of the nursing intervention of ceftazidime tazobactam sodium combined with Levofloxacin in treating heart failure complicated with lung infection in elderly patients. Patients in the control group (n = 59) accepted ceftazidime tazobactam sodium injection (3:1). Patients in the observation group (n = 59) were given levofloxacin […]
Objective: To probe the clinical value of fire-dragon moxibustion treatment based on Fuyang Tongbi theory in wind-colddampness rheumatoid arthritis (R.A.) patients. Methods: 80 patients with joint pain were selected, including 40 in the fire-dragon moxibustion group and 40 in the conventional group. Patients in the traditional group accepted non-steroidal anti-inflammatory drugs and other Chinese and […]
Objective: To investigate the effect of sevoflurane postconditioning on the levels of Nrf2 expressed in the early stage of hepatic ischemia-reperfusion injury (HIRI) in rats and to explore the possible Mechanism of sevoflurane postconditioning in attenuating HIRI. Methods: 24 S.D. rats were randomly divided into Sham group, Sevoflurane group, HIRI group, and HIRI+Sevoflurane group. The […]